The changing face of diabetes in youth: Lessons learned from studies of type 2 diabetes

Annals of the New York Academy of Sciences

Volumn 1353, Issue 1, 2015, Pages 113-137

  Hannon, Tamara S ^a   Arslanian, Silva A ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Adolescent; Insulin secretion; Insulin sensitivity; Obesity; Pathophysiology; Treatment

Indexed keywords

AUTOANTIBODY; METFORMIN;

ADULT DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CELL FUNCTION; GENETIC HETEROGENEITY; HISTORY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MACROVASCULAR COMPLICATION; MICROANGIOPATHY; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHENOTYPE; RISK FACTOR; ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 2; PANCREAS ISLET; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MULTICENTER STUDIES AS TOPIC; PREDIABETIC STATE; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84945291500     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12939     Document Type: Article

References (209)

1. Rowe, P.A., M.L. Campbell-Thompson, D.A. Schatz, et al. 2011. The pancreas in human type 1 diabetes. Semin. Immunopathol. 33: 29-43.
2. Friday, R.P., M. Trucco & M. Pietropaolo . 1999. Genetics of type 1 diabetes mellitus. Diabetes Nutr. Metab. 12: 3-26.
3. Haller, M.J., M.A. Atkinson & D. Schatz . 2005. Type 1 diabetes mellitus: etiology, presentation, and management. Pediatr. Clin. North Am. 52: 1553-1578.
4. Gungor, N., T. Hannon, I. Libman, et al. 2005. Type 2 diabetes mellitus in youth: the complete picture to date. Pediatr. Clin. North Am. 52: 1579-1609.
5. Rivera-Vega, M, I. Libman & S. Arslanian . 2014. "Obesity and type 2 diabetes in children." In Therapy for Diabetes Mellitus and Related Disorders. G.E. Umpierrez, Ed.: 263-283. Alexandria, VA: American Diabetes Association.
6. Gungor, N., F. Bacha, R. Saad, et al. 2005. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care 28: 638-644.
7. Michaliszyn, S.F., A. Mari, S. Lee, et al. 2014. Beta-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes 63: 3846-3855.
8. Tfayli, H., F. Bacha, N. Gungor, et al. 2010. Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two? Diabetes Care 33: 632-638.
9. Tfayli, H., F. Bacha, N. Gungor, et al. 2009. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes 58: 738-744.
10. Danaei, G., M.M. Finucane, Y. Lu, et al. 2011. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378: 31-40.
11. Danaei, G., A.B. Friedman, S. Oza, et al. 2009. Diabetes prevalence and diagnosis in US states: analysis of health surveys. Popul. Health Metr. 7: 16.
12. Dabelea, D., E.J. Mayer-Davis, S. Saydah, et al. 2014. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311: 1778-1786.
13. Copeland, K.C., P. Zeitler, M. Geffner, et al. 2011. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J. Clin. Endocrinol. Metab. 96: 159-167.
14. Libman, I.M., M. Pietropaolo, S.A. Arslanian, et al. 2003. Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 26: 2871.
15. Liu, L.L., J.M. Lawrence, C. Davis, et al. 2010. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr. Diabetes 11: 4.
16. Redondo, M.J., C.G. Connor, K.J. Ruedy, et al. 2014. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis. Pediatr. Diabetes 15: 294-302.
17. Zeitler, P., K. Hirst, L. Pyle, et al. for TODAY Study Group 2012. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N. Engl. J. Med. 366: 2247-2256.
18. Mottl, A.K., A. Lauer, D. Dabelea, et al. 2013. Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes. Diabetes Care 36: 3633-3638.
19. Dabelea, D., J.W. Talton, R. D'Agostino Jr., et al. 2013. Cardiovascular risk factors are associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care 36: 3938-3943.
20. Mayer-Davis, E.J., C. Davis, J. Saadine, et al. 2012. Diabetic retinopathy in the SEARCH for Diabetes in Youth Cohort: a pilot study. Diabet. Med. 29: 1148-1152.
21. Hirst, K., T. Baranowski, L. DeBar, et al. 2009. HEALTHY study rationale, design and methods: moderating risk of type 2 diabetes in multi-ethnic middle school students. Int. J. Obes. (Lond.) 33(Suppl. 4): S4-S20.
22. Baranowski, T., D.M. Cooper, J. Harrell, et al. 2006. Presence of diabetes risk factors in a large U.S. eighth-grade cohort. Diabetes Care 29: 212-217.
23. Foster, G.D., B. Linder, T. Baranowski, et al. 2010. A school-based intervention for diabetes risk reduction. N. Engl. J. Med. 363: 443-453.
24. World Health Organization. 2011. Global status report on noncommunicable diseases, 2010. Geneva: World Health Organization.
25. International Diabetes Federation. 2013. IDF Diabetes Atlas. 6th ed. Brussels, Belgium. http://www.Idf.Org/diabetesatlas. Accessed September 8, 2015.
26. National Center for Health Statistics, Centers for Disease Control and Prevention, U.S. Census Bureau. 2012. National health interview survey.
27. The DIAMOND Project Group. 2006. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet. Med. 23: 857-866.
28. Patterson, C.C., G.G. Dahlquist, E. Gyurus, et al. 2009. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373: 2027-2033.
29. Patterson, C.C., E. Gyurus, J. Rosenbauer, et al. 2012. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 55: 2142-2147.
30. Fazeli Farsani, S., M.P. van der Aa, M.M. van der Vorst, et al. 2013. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia 56: 1471-1488.
31. Savage, P.J., P.H. Bennett, R.G. Senter, et al. 1979. High prevalence of diabetes in young Pima Indians: evidence of phenotypic variation in a genetically isolated population. Diabetes 28: 937-942.
32. Pinhas-Hamiel, O., L.M. Dolan, S.R. Daniels, et al. 1996. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J. Pediatr. 128: 608-615.
33. Pinhas-Hamiel, O. & P. Zeitler . 2005. The global spread of type 2 diabetes mellitus in children and adolescents. J. Pediatr. 146: 693-700.
34. Imperatore, G., J.P. Boyle, T.J. Thompson, et al. 2012. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 35: 2515-2520.
35. Klingensmith, G.J., L. Pyle, S. Arslanian, et al. 2010. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care 33: 1970-1975.
36. Brooks-Worrell, B.M., C.J. Greenbaum, J.P. Palmer, et al. 2004. Autoimmunity to islet proteins in children diagnosed with new-onset diabetes. J. Clin. Endocrinol. Metab. 89: 2222-2227.
37. Gilliam, L.K., B.M. Brooks-Worrell, J.P. Palmer, et al. 2005. Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes. J. Autoimmun. 25: 244-250.
38. Hathout, E.H., W. Thomas, M. El-Shahawy, et al. 2001. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics 107: E102.
39. Reinehr, T., E. Schober, S. Wiegand, et al. 2006. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch. Dis. Child. 91: 473-477.
40. Rivera-Vega, M.Y., A. Flint, D.G. Winger, et al. 2015. Obesity and youth diabetes: distinguishing characteristics between islet cell antibody positive vs. negative patients over time. Pediatr. Diabetes 16: 375-381.
41. Umpaichitra, V., M.A. Banerji & S. Castells . 2002. Autoantibodies in children with type 2 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 15(Suppl. 1): 525-530.
42. American Diabetes Association. 2014. Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl. 1): S81-S90.
43. Li, C., E.S. Ford, G. Zhao, et al. 2009. Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006. Diabetes Care 32: 342-347.
44. May, A.L., E.V. Kuklina & P.W. Yoon . 2012. Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Pediatrics 129: 1035-1041.
45. Weiss, R., J. Dziura, T.S. Burgert, et al. 2004. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350: 2362-2374.
46. Kaufman, F.R., K. Hirst, B. Linder, et al. 2009. Risk factors for type 2 diabetes in a sixth-grade multiracial cohort: the HEALTHY study. Diabetes Care 32: 953-955.
47. Kahn, S.E., R.L. Prigeon, D.K. McCulloch, et al. 1993. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672.
48. Defronzo, R.A. 2009. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795.
49. Tahrani, A.A., C.J. Bailey, S. Del Prato, et al. 2011. Management of type 2 diabetes: new and future developments in treatment. Lancet 378: 182-197.
50. Weiss, R., S. Caprio, M. Trombetta, et al. 2005. Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 54: 1735-1743.
51. Kobayashi, K., S. Amemiya, K. Higashida, et al. 2000. Pathogenic factors of glucose intolerance in obese Japanese adolescents with type 2 diabetes. Metabolism 49: 186-191.
52. Elder, D.A., R.L. Prigeon, R.P. Wadwa, et al. 2006. Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. J. Clin. Endocrinol. Metab. 91: 185-191.
53. Druet, C., N. Tubiana-Rufi, D. Chevenne, et al. 2006. Characterization of insulin secretion and resistance in type 2 diabetes of adolescents. J. Clin. Endocrinol. Metab. 91: 401-404.
54. Elder, D.A., J.G. Woo & D.A. D'Alessio . 2010. Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes. Pediatr. Diabetes 11: 314-321.
55. Bacha, F., L. Pyle, K. Nadeau, et al. 2012. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr. Diabetes 13: 376-383.
56. Umpaichitra, V., W. Bastian, D. Taha, et al. 2001. C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 86: 1605-1609.
57. Weiss, R., E. D'Adamo, N. Santoro, et al. 2011. Basal alpha-cell up-regulation in obese insulin-resistant adolescents. J. Clin. Endocrinol. Metab. 96: 91-97.
58. Goldfine, A.B., C. Bouche, R.A. Parker, et al. 2003. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc. Natl. Acad. Sci. U. S. A. 100: 2724-2729.
59. Kahn, S.E. 2003. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46: 3-19.
60. Bacha, F., N. Gungor, S. Lee, et al. 2009. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care 32: 100-105.
61. Bacha, F., S. Lee, N. Gungor, et al. 2010. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care 33: 2225-2231.
62. Tfayli, H., S. Lee & S. Arslanian . 2010. Declining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in children. Diabetes Care 33: 2024-2030.
63. Burns, S.F., F. Bacha, S.J. Lee, et al. 2011. Declining beta-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. Diabetes Care 34: 2033-2040.
64. Giannini, C., R. Weiss, A. Cali, et al. 2012. Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. Diabetes 61: 606-614.
65. Goran, M.I., R.N. Bergman, Q. Avila, et al. 2004. Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes. J. Clin. Endocrinol. Metab. 89: 207-212.
66. Weigensberg, M.J., G.D. Ball, G.Q. Shaibi, et al. 2005. Decreased beta-cell function in overweight Latino children with impaired fasting glucose. Diabetes Care 28: 2519-2524.
67. Weiss, R., S.E. Taksali, W.V. Tamborlane, et al. 2005. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 28: 902-909.
68. Sjaarda, L.A., S.F. Michaliszyn, S. Lee, et al. 2012. HbA(1c) diagnostic categories and beta-cell function relative to insulin sensitivity in overweight/obese adolescents. Diabetes Care 35: 2559-2563.
69. Arslanian, S. 2002. Type 2 diabetes in children: clinical aspects and risk factors. Horm. Res. 57(Suppl. 1): 19-28.
70. Gungor, N. & S. Arslanian . 2004. Progressive beta cell failure in type 2 diabetes mellitus of youth. J. Pediatr. 144: 656-659.
71. Matthews, D.R., C.A. Cull, I.M. Stratton, et al. 1998. UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet. Med. 15: 297-303.
72. Turner, R.C., C.A. Cull, V. Frighi, et al. 1999. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281: 2005-2012.
73. Bacha, F., N. Gungor, S. Lee, et al. 2013. Progressive deterioration of beta-cell function in obese youth with type 2 diabetes. Pediatr. Diabetes 14: 106-111.
74. Levitt Katz, L.E., S.N. Magge, M.L. Hernandez, et al. 2011. Glycemic control in youth with type 2 diabetes declines as early as two years after diagnosis. J. Pediatr. 158: 106-111.
75. Arslanian S, L. Pyle, M. Payan, et al. for The TODAY Study Group. 2013. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and beta-cell function in TODAY. Diabetes Care 36: 1749-1757.
76. Dabelea, D., E.J. Mayer-Davis, J.S. Andrews, et al. 2012. Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 55: 3359-3368.
77. Babaoglu, K., S. Hatun, I. Arslanoglu, et al. 2006. Evaluation of glucose intolerance in adolescents relative to adults with type 2 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 19: 1319-1326.
78. Nguyen, Q.M., S.R. Srinivasan, J.H. Xu, et al. 2009. Influence of childhood parental history of type 2 diabetes on the pre-diabetic and diabetic status in adulthood: the Bogalusa Heart Study. Eur. J. Epidemiol. 24: 537-539.
79. Rodriguez-Moran, M., F. Guerrero-Romero, C. Aradillas-Garcia, et al. 2010. Obesity and family history of diabetes as risk factors of impaired fasting glucose: implications for the early detection of prediabetes. Pediatr. Diabetes 11: 331-336.
80. Meigs, J.B., L.A. Cupples & P.W. Wilson . 2000. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 49: 2201-2207.
81. Sartorius, T., H. Staiger, C. Ketterer, et al. 2012. Association of common genetic variants in the MAP4K4 locus with prediabetic traits in humans. PLoS One 7: e47647.
82. Arslanian, S.A., F. Bacha, R. Saad, et al. 2005. Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care 28: 115-119.
83. Giannini, C., C. Dalla Man, L. Groop, et al. 2014. Co-occurrence of risk alleles in or near genes modulating insulin secretion predisposes obese youth to prediabetes. Diabetes Care 37: 475-482.
84. Kwak, S.H. & K.S. Park . 2013. Genetics of type 2 diabetes and potential clinical implications. Arch. Pharm. Res. 36: 167-177.
85. So, H.C., A.H.S. Gui, S.S. Cherny, et al. 2011. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet. Epidemiol. 35: 310-317.
86. Billings, L.K. & J.C. Florez . 2010. The genetics of type 2 diabetes: what have we learned from GWAS? Ann. N. Y. Acad. Sci. 1212: 59-77.
87. Gill-Carey, O. & A.T. Hattersley . 2007. Genetics and type 2 diabetes in youth. Pediatr. Diabetes 8(Suppl. 9): 42-47.
88. Dabelea, D., L.M. Dolan, R. D'Agostino Jr. et al. 2011. Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth. Diabetologia 54: 535-539.
89. Dabelea, D. 2007. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care 30(Suppl. 2): S169-S174.
90. McMillen, I.C., L. Rattanatray, J.A. Duffield, et al. 2009. The early origins of later obesity: pathways and mechanisms. Adv. Exp. Med. Biol. 646: 71-81.
91. Centers for Disease Control and Prevention. 2014. National diabetes fact sheet: national diabetes estimates and general information on diabetes and prediabetes in the United States, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. Accessed September 14, 2015.
92. Dabelea, D., E.J. Mayer-Davis, A.P. Lamichhane, et al. 2008. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care 31: 1422-1426.
93. Arslanian, S.A. 2002. Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 15(Suppl. 1): 509-517.
94. Bacha, F., R. Saad, N. Gungor, et al. 2003. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J. Clin. Endocrinol. Metab. 88: 2534-2540.
95. Hasson, R.E., T.C. Adam, J.N. Davis, et al. 2010. Ethnic differences in insulin action in obese African-American and Latino adolescents. J. Clin. Endocrinol. Metab. 95: 4048-4051.
96. Bacha, F., N. Gungor, S. Lee, et al. 2012. Type 2 diabetes in youth: are there racial differences in beta-cell responsiveness relative to insulin sensitivity? Pediatr. Diabetes 13: 259.
97. Ball, G.D., T.T. Huang, B.A. Gower, et al. 2006. Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty. J. Pediatr. 148: 16-22.
98. Weiss, R., J.D. Dziura, T.S. Burgert, et al. 2006. Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents. Diabetologia 49: 571-579.
99. Goran, M.I. & B.A. Gower . 2001. Longitudinal study on pubertal insulin resistance. Diabetes 50: 2444-2450.
100. Hannon, T.S., J. Janosky & S.A. Arslanian . 2006. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr. Res. 60: 769-763.
101. Kelly, L.A., C.J. Lane, M.J. Weigensberg, et al. 2011. Pubertal changes of insulin sensitivity, acute insulin response, and beta-cell function in overweight Latino youth. J. Pediatr. 158: 442-446.
102. Carnethon, M.R., L.S. Kinder, J.M. Fair, et al. 2003. Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971-1992. Am. J. Epidemiol. 158: 416-423.
103. Hannon, T.S., D.L. Rofey, S. Lee, et al. 2013. Depressive symptoms and metabolic markers of risk for type 2 diabetes in obese adolescents. Pediatr. Diabetes 14: 497-503.
104. Jaser, S.S., M.G. Holl, V. Jefferson, et al. 2009. Correlates of depressive symptoms in urban youth at risk for type 2 diabetes mellitus. J. Sch. Health 79: 286-292.
105. Kinder, L.S., M.R. Carnethon, L.P. Palaniappan, et al. 2004. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom. Med. 66: 316-322.
106. Scott, K.M., M. Von Korff, M.C. Angermeyer, et al. 2011. Association of childhood adversities and early-onset mental disorders with adult-onset chronic physical conditions. Arch. Gen. Psychiatry 68: 838-844.
107. Shomaker, L.B., M. Tanofsky-Kraff, E.A. Stern, et al. 2011. Longitudinal study of depressive symptoms and progression of insulin resistance in youth at risk for adult obesity. Diabetes Care 34: 2458-2463.
108. Shomaker, L.B., M. Tanofsky-Kraff, D. Young-Hyman, et al. 2010. Psychological symptoms and insulin sensitivity in adolescents. Pediatr. Diabetes 11: 417-423.
109. Cappuccio, F.P., L. D'Elia, P. Strazzullo, et al. 2010. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 33: 414-420.
110. de la Eva, R.C., L.A. Baur, K.C. Donaghue, et al. 2002. Metabolic correlates with obstructive sleep apnea in obese subjects. J. Pediatr. 140: 654-659.
111. Hannon, T.S., S. Lee, S. Chakravorty, et al. 2011. Sleep-disordered breathing in obese adolescents is associated with visceral adiposity and markers of insulin resistance. Int. J. Pediatr. Obes. 6: 157-160.
112. Koren, D., L.E. Levitt Katz, P.C. Brar, et al. 2011. Sleep architecture and glucose and insulin homeostasis in obese adolescents. Diabetes Care 34: 2442-2447.
113. Lesser, D.J., R. Bhatia, W.H. Tran, et al. 2012. Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino males. Pediatr. Res. 72: 293-298.
114. Matthews, K.A., R.E. Dahl, J.F. Owens, et al. 2012. Sleep duration and insulin resistance in healthy black and white adolescents. Sleep 35: 1353-1358.
115. Pamidi, S., K. Wroblewski, J. Broussard, et al. 2012. Obstructive sleep apnea in young lean men: impact on insulin sensitivity and secretion. Diabetes Care 35: 2384-2389.
116. Pyykkonen, A.J., B. Isomaa, A.K. Pesonen, et al. 2012. Subjective sleep complaints are associated with insulin resistance in individuals without diabetes: the PPP-Botnia Study. Diabetes Care 35: 2271-2278.
117. Watson, S.E., Z. Li, W. Tu, et al. 2014. Obstructive sleep apnoea in obese adolescents and cardiometabolic risk markers. Pediatr. Obes. 9: 471-477.
118. Hannon, T.S., W. Tu, S.E. Watson, et al. 2014. Morning blood pressure is associated with sleep quality in obese adolescents. J. Pediatr. 164: 313-317.
119. American Diabetes Association. 2013. Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl. 1): S67-S74.
120. American Diabetes Association. 2000. Type 2 diabetes in children and adolescents. Diabetes Care 23: 381-389.
121. American Diabetes Association. 2000. Type 2 diabetes in children and adolescents. Pediatrics 105: 671-680.
122. American Diabetes Association. 2011. Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl. 1): S62-S69.
123. Buell, C., D. Kermah & M.B. Davidson . 2007. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care 30: 2233-2235.
124. Rohlfing, C.L., R.R. Little, H.M. Wiedmeyer, et al. 2000. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 23: 187-191.
125. Sabanayagam, C., G. Liew, E.S. Tai, et al. 2009. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia 52: 1279-1289.
126. Hanas, R. & G. John . 2010. 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 33: 1903-1904.
127. Nathan, D.M., H. Turgeon & S. Regan . 2007. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 50: 2239-2244.
128. Lee, J.M., E.L. Wu, B. Tarini, et al. 2011. Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents? J. Pediatr. 158: 947-952. e1-3.
129. Kapadia, C.R. 2013. Are the ADA hemoglobin A1c criteria relevant for the diagnosis of type 2 diabetes in youth? Curr. Diab. Rep. 13: 51-55.
130. Nowicka, P., N. Santoro, H. Liu, et al. 2011. Utility of hemoglobin A1c for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 34: 1306-1311.
131. Lipton, R.B., M. Drum, D. Burnet, et al. 2005. Obesity at the onset of diabetes in an ethnically diverse population of children: what does it mean for epidemiologists and clinicians? Pediatrics 115: e553-e560.
132. Dabelea, D., C. Pihoker, J.W. Talton, et al. 2011. Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study. Diabetes Care 34: 1628-1633.
133. Wang, J., D. Miao, S. Babu, et al. 2007. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J. Clin. Endocrinol. Metab. 92: 88-92.
134. Domargard, A., S. Sarnblad, M. Kroon, et al. 1999. Increased prevalence of overweight in adolescent girls with type 1 diabetes mellitus. Acta Paediatr. 88: 1223-1228.
135. Hypponen, E., S.M. Virtanen, M.G. Kenward, et al. 2000. Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 23: 1755-1760.
136. Sandhu, N., M.B. Witmans, J.F. Lemay, et al. 2008. Prevalence of overweight and obesity in children and adolescents with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 21: 631-640.
137. Nagasaka, S., S. Ishikawa, N. Itabashi, et al. 1998. Ketoacidosis-onset type 2 diabetes in Japanese. Association with the widespread distribution of soft drinks and vending machines. Diabetes Care 21: 1376-1378.
138. Pinhas-Hamiel, O., L.M. Dolan & P.S. Zeitler . 1997. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 20: 484-486.
139. The SEARCH Study Group. 2004. SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control. Clin. Trials 25: 458-471.
140. Pozzilli, P., C. Guglielmi, E. Pronina, et al. 2007. Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths. Pediatr. Diabetes 8(Suppl. 9): 88-95.
141. Lee S., F. Bacha & S.A. Arslanian . 2006. Waist circumference, blood pressure and lipid components of the metabolic syndrome. J. Pediatr. 149: 809-816.
142. Lee S., N. Gungor, F. Bacha, et al. 2007. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care 30: 2091-2097.
143. Bacha, F., N. Gungor, S. Lee, et al. 2013. Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes. J. Pediatr. 162: 924-929.
144. Smith, R.J., D.M. Nathan, S.A. Arslanian, et al. 2010. Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know. J. Clin. Endocrinol. Metab. 95: 1566-1574.
145. Zeitler, P., J. Fu, N. Tandon, et al. 2014. Type 2 diabetes in the child and adolescent. Pediatr. Diabetes 15(Suppl. 20): 26-46.
146. Jones, K.L., S. Arslanian, V.A. Peterokova, et al. 2002. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 25: 89-94.
147. Knowler, W.C., E. Barrett-Connor, S.E. Fowler, et al. 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346: 393-403.
148. Lee, S., F. Bacha, N. Gungor, et al. 2006. Cardiorespiratory fitness in youth: relationship to insulin sensitivity and beta-cell function. Obesity 14: 1579-1585.
149. Lee, S., A.R. Deldin, D. White, et al. 2013. Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial. Am. J. Physiol. Endocrinol. Metab. 305: E1222-E1229.
150. Lee, S., F. Bacha, T. Hannon, et al. 2012. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes 61: 2787-2795.
151. Rosenbloom, A.L., J.H. Silverstein, S. Amemiya, et al. 2008. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Type 2 diabetes mellitus in the child and adolescent. Pediatr. Diabetes 9: 512-526.
152. The TODAY Study Group. 2013. Treatment effects on measures of body composition in the TODAY clinical trial. Diabetes Care 36: 1742-1748.
153. American Diabetes Association. 2014. Standards of medical care in diabetes-2014. Diabetes Care 37(Suppl. 1): S14-S80.
154. Rothman, R.L., S. Mulvaney, T.A. Elasy, et al. 2008. Self-management behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes. Pediatrics 121: e912-e919.
155. Brown, J.B., C. Conner & G.A. Nichols . 2010. Secondary failure of metformin monotherapy in clinical practice. Diabetes Care 33: 501-506.
156. Kahn, S.E., S.M. Haffner, M.A. Heise, et al. 2006. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N. Engl. J. Med. 355: 2427-2443.
157. Karres, J., V. Pratt, J.M. Guettier, et al. 2014. Joining forces: a call for greater collaboration to study new medicines in children and adolescents with type 2 diabetes. Diabetes Care 37: 2665-2667.
158. Williams, R., M. Airey, H. Baxter, et al. 2004. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 18: 963-983.
159. Molitch, M.E., R.A. DeFronzo, M.J. Franz, et al. 2004. Nephropathy in diabetes. Diabetes Care 27(Suppl. 1): S79-S83.
160. Keane, W.F., B.M. Brenner, D. de Zeeuw, et al. 2003. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 63: 1499-1507.
161. Boulton, A.J. 2014. Diabetic neuropathy and foot complications. Handb. Clin. Neurol. 126: 97-107.
162. Jude, E.B. & A.J. Boulton . 1999. Peripheral neuropathy. Clin. Podiatr. Med. Surg. 16: 81-96.
163. The TODAY Study Group. 2013. Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 36: 1758-1764.
164. The TODAY Study Group. 2013. Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Care 36: 1772-1774.
165. The TODAY Study Group. 2013. Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience. Diabetes Care 36: 1765-1771.
166. The TODAY Study Group. 2013. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 36: 1735-1741.
167. Jaiswal, M., A. Lauer, C.L. Martin, et al. 2013. Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for Diabetes in Youth follow-up cohort: a pilot study. Diabetes Care 36: 3903-3908.
168. Pinhas-Hamiel O & P. Zeitler . 2007. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 369: 1823-1831.
169. Hamman, R.F., R.A. Bell, D. Dabelea, et al. 2014. The SEARCH for Diabetes in Youth Study: rational, findings, and future directions. Diabetes Care 37: 3336-3344.
170. Springer, S.C., J. Silverstein, K. Copeland, et al. 2013. Management of type 2 diabetes mellitus in children and adolescents. Pediatrics 131: e648-e664.
171. Kohner, E.M., S.J. Aldington, I.M. Stratton, et al. 1998. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch. Ophthalmol. 116: 297-303.
172. Krakoff, J., R.S. Lindsay, H.C. Looker, et al. 2003. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care 26: 76-81.
173. van Leiden, H.A., J.M. Dekker, A.C. Moll, et al. 2003. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch. Ophthalmol. 121: 245-251.
174. van Leiden, H.A., J.M. Dekker, A.C. Moll, et al. 2002. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 25: 1320-1325.
175. Kawasaki, R., S. Tanaka, S. Abe, et al. 2013. Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study. Ophthalmology 120: 574-582.
176. Walraven, I., K. van den Hurk, E. van 't Riet, et al. 2014. Low-grade inflammation and endothelial dysfunction explain the association between retinopathy and left ventricular ejection fraction in men: an 8-year follow-up of the Hoorn Study. J. Diabetes Complications 28: 819-823.
177. Wong, T.Y., E.L. Barr, R.J. Tapp, et al. 2005. Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Am. J. Ophthalmol. 140: 1157-1159.
178. Gerstein, H.C., W.T. Ambrosius, R. Danis, et al. 2013. Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes Care 36: 1266-1271.
179. Sairenchi, T., H. Iso, K. Yamagishi, et al. 2011. Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study. Circulation 124: 2502-2511.
180. Kramer, C.K., T.C. Rodrigues, L.H. Canani, et al. 2011. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care 34: 1238-1244.
181. Eppens, M.C., M.E. Craig, J. Cusumano, et al. 2006. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29: 1300-1306.
182. Maahs, D.M., B.M. Snively, R.A. Bell, et al. 2007. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care 30: 2593-2598.
183. Yokoyama, H., M. Okudaira, T. Otani, et al. 2000. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Kidney Int. 58: 302-311.
184. Pavkov, M.E., P.H. Bennett, W.C. Knowler, et al. 2006. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 296: 421-426.
185. Dart, A.B., E.A. Sellers, P.J. Martens, et al. 2012. High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care 35: 1265-1271.
186. Pilz, S., F. Rutters, G. Nijpels, et al. 2014. Insulin sensitivity and albuminuria: the RISC study. Diabetes Care 37: 1597-1603.
187. Eller, K., A. Kirsch, A.M. Wolf, et al. 2011. Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes 60: 2954-2962.
188. McMullan, C.J., H.J. Lambers Heerspink, H.H. Parving, et al. 2014. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial. Am. J. Kidney Dis. 64: 714-722.
189. Okada, H., M. Fukui, M. Tanaka, et al. 2012. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 220: 155-159.
190. Kilpatrick, E.S., A.S. Rigby & S.L. Atkin . 2010. The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care 33: 2442-2447.
191. Nathan, D.M., P.A. Cleary, J.Y. Backlund, et al. 2005. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353: 2643-2653.
192. Goff, D.C., Jr., H.C. Gerstein, H.N. Ginsberg, et al. 2007. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am. J. Cardiol. 99: 4i-20i.
193. Kershnar, A.K., S.R. Daniels, G. Imperatore, et al. 2006. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study. J. Pediatr. 149: 314-319.
194. Sellers, E.A., G. Yung & H.J. Dean . 2007. Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus. Pediatr. Diabetes 8: 384-390.
195. Margolis, K.L., P.J. O'Connor, T.M. Morgan, et al. 2014. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. Diabetes Care 37: 1721-1728.
196. Gungor, N., T. Thompson, K. Sutton-Tyrrell, et al. 2005. Early signs of cardiovascular disease in youth with obesity and type 2 diabetes. Diabetes Care 28: 1219-1221.
197. Wadwa, R.P., E.M. Urbina, A.M. Anderson, et al. 2010. Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study. Diabetes Care 33: 881-886.
198. Bacha, F., D. Edmundowicz, K. Sutton-Tyrell, et al. 2014. Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants? Diabetes Care 37: 2632-2639.
199. Kavey, R.E., V. Allada, S.R. Daniels, et al. 2006. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114: 2710-2738.
200. Dart, A.B., P.J. Martens, C. Rigatto, et al. 2014. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care 37: 436-443.
201. Constantino, M.I., L. Molyneaux, F. Limacher-Gisler, et al. 2013. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care 36: 3863-3869.
202. Rascati, K., K. Richards, D. Lopez, et al. 2013. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database. Diabetes Obes. Metab. 15: 901-905.
203. Williams, L.K., B. Padhukasahasram, B.K. Ahmedani, et al. 2014. Differing effects of metformin on glycemic control by race-ethnicity. J. Clin. Endocrinol. Metab. 99: 3160-3168.
204. Kahn, S.E., J.M. Lachin, B. Zinman, et al. 2011. Effects of rosiglitazone, glyburide, and metformin on beta-cell function and insulin sensitivity in ADOPT. Diabetes 60: 1552-1560.
205. Kahn, S.E. 2001. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J. Clin. Endocrinol. Metab. 86: 4047-4058.
206. Ekholm, E., A. Gottsater, L.B. Dahlin, et al. 2012. No signs of progressive beta cell damage during 20 years of prospective follow-up of autoantibody-negative diabetes. Acta Diabetol. 49: 57-62.
207. Borg, H., A. Gottsater, P. Fernlund, et al. 2002. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51: 1754-1762.
208. Linder, B.L., J.E. Fradkin & G.P. Rodgers . 2013. The TODAY study: an NIH perspective on its implications for research. Diabetes Care 36: 1775-1776.
209. Cefalu, W.T. 2014. A "spoonful of sugar" and the realities of diabetes prevention! Diabetes Care 37: 906-908.